RGT — Argent BioPharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Argent BioPharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	5.43	1.89	0.24	0.703	1.02
Net Total Accounts Receivable
Net Total Receivables	2.35	1.94	0.531	0.477	0.376
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9.48	6.46	2.53	2.74	2.03
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.14	8.8	7.45	6.72	0.438
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	24.2	18.6	9.98	10.8	2.47
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.13	7.71	13.3	12.2	10.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	10.4	12.7	17.4	15.9	11.1
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13.8	5.84	-7.4	-5.15	-8.63
Total Liabilities & Shareholders' Equity	24.2	18.6	9.98	10.8	2.47
Total Common Shares Outstanding